404
+1-313-307-4176
sales@stratviewresearch.com
Cosmetic Surgery And Procedures Market Report
Cosmetic Surgery and Procedures Market Size, Share, Trends & Forecast Analysis: 2022-2028
The Cosmetic Surgery and Procedures market is projected to grow from USD 64.16 billion in 2021 to USD 120.21 billion by 2028 at a CAGR of around 9.28% during the forecast period of 2022-2028.
Cosmetic surgery is defined as a process that enhances a portion of an individual’s body or faces through the incision. Cosmetic surgeries include altering facial structure (maxillofacial), reconstruction or reshaping of body parts, and altering the structure of the jaw (craniofacial) among others.
The growth of the cosmetic surgery and procedures market is primarily driven by an increasing number of cosmetic surgeries across geographies. Growing consciousness among consumers related to personal aesthetics coupled with rising per capita disposable income of the consumers is expected to propel the market growth at a significant rate during the review period. Additionally, a growing emphasis on research and development activities to develop advanced surgical procedures is likely to create lucrative opportunities for the market players during the review period.
The outbreak of the COVID-19 virus has affected the growth of the healthcare industry significantly. Stringent lockdown measures and restricted movement of people affected the product supply for a short period and thus, affected the market growth.
Key players operating in the Cosmetic Surgery and Procedures Market are-
By end-user, the cosmetic surgery and procedures market has been bifurcated into hospitals, office-based facilities, and ambulatory surgical centers. Under these, the hospitals' segment accounted for the largest market share in 2021 and is projected to register significant growth during the review period.
By region, the market in North America accounted for the largest share of more than 33.33% in 2021 and is projected to grow at a significant CAGR during the assessment period. The regional growth is primarily attributed to expanding geriatric populace and rising incidences of skin disorders coupled with the presence of key market players such as Genesis Biosystems (US) and A.P. Pharma, Inc. (US). The market growth in the Asia-Pacific region is expected to be driven by increased spending on cosmetic surgeries and rising medical tourism.
This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both the qualitative and quantitative insights.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
Here is the list of the group of customers that the cosmetic surgery and procedures market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.
The cosmetic surgery and procedures market is expected to witness an impressive growth of 9.28% CAGR during 2022-2028.
Sanofi S.A. (France), Bausch Health Companies Inc. (Canada), Lumenis (Israel), Genesis Biosys-tems (US), Covidien (Ireland), A.P. Pharma, Inc. (US), Zeltiq Aesthetics (US), Cynosure (US), Al-lergan, Inc. (Ireland), Merz Pharma GmbH & Co. KGaA (Germany), Cutera, Inc. (US), Ipsen (France), Sientra (US), ALMA LASERS LTD. (Israel) and Johnson & Johnson (US) are among the key players in the market.
The cosmetic surgery and procedures market size is expected to reach USD 120.21 billion in 2028.
The hospitals' segment is expected to register significant growth in the market in the coming years.
North America accounted for the largest share in the market in 2021.
Cosmetic surgery and procedures distributors, Cosmetic surgery and procedures suppliers, Cosmetic surgery and procedures manufacturers, Logistics organizations, Government bodies are the target audience in the market.
WE ACCEPT
